Gyre Therapeutics (GYRE) Raw Materials (2022 - 2025)
Historic Raw Materials for Gyre Therapeutics (GYRE) over the last 4 years, with Q3 2025 value amounting to $1.1 million.
- Gyre Therapeutics' Raw Materials rose 577.48% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 577.48%. This contributed to the annual value of $794000.0 for FY2024, which is 1360.17% down from last year.
- Per Gyre Therapeutics' latest filing, its Raw Materials stood at $1.1 million for Q3 2025, which was up 577.48% from $1.2 million recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Raw Materials ranged from a high of $1.2 million in Q2 2025 and a low of $724000.0 during Q1 2024
- Its 4-year average for Raw Materials is $1.0 million, with a median of $1.1 million in 2022.
- Per our database at Business Quant, Gyre Therapeutics' Raw Materials crashed by 1360.17% in 2024 and then soared by 6146.41% in 2025.
- Gyre Therapeutics' Raw Materials (Quarter) stood at $1.1 million in 2022, then fell by 12.97% to $919000.0 in 2023, then dropped by 13.6% to $794000.0 in 2024, then soared by 38.41% to $1.1 million in 2025.
- Its Raw Materials was $1.1 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.2 million in Q1 2025.